Progrediente Dyspnoe bei neuroendokrinem Tumor

Davar J, Connolly HM, Caplin ME, Pavel M, Zacks J, Bhattacharyya S, Cuthbertson DJ, Dobson R, Grozinsky-Glasberg S, Steeds RP, Dreyfus G, Pellikka PA, Toumpanakis C (2017) Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol 69:1288–1304

Luis SA, Pellikka PA (2016) Carcinoid heart disease: diagnosis and management. Best Pract Res Clin Endocrinol Metab 30:149–158

Patel C, Mathur M, Escarceger RO, Bove AA (2014) Carcinoid heart disease: current understanding and future directions. Am Heart J 167:789–795

Raja SG, Bhattacharyya S, Davar J et al (2010) Surgery of carcinoid heart disease: current outcomes, concerns and controversies. Future Cardiol 6:647–655

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O’Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera SM, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E (2017) Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med 376(2):125–135

Zengin E, Sinning C, Schäfer U (2016) Interventional treatment of a falling pulmonic and tricuspid bioprothesis in Hedinger Syndrome. J Am Coll Cardiol 9(15):e145–e146